Background <p>Korean Medicine (KM) has been a vital part of healthcare, providing holistic treatment approaches for diverse conditions. With the growing demand for integration with conventional medical frameworks, the development of evidence-based clinical practice guidelines (CPGs) has become essential. These guidelines aim to ensure consistent and effective care while enhancing the credibility of KM in the global healthcare community. </p> Methods <p>This review comprehensively analyzed the latest KM CPGs to examine their distribution across diseases, levels of evidence, and strengths of recommendations. The analysis categorized guidelines into key clinical focus areas, assessed the supporting evidence, and evaluated the strength of recommendations provided.</p> Results <p>KM CPGs primarily address musculoskeletal, symptom-based, mental, and nervous system disorders, reflecting critical areas of clinical application. Most recommendations are supported by moderate evidence, with high-strength (Grade A) recommendations encompassing treatments such as acupuncture, pharmacopuncture, herbal medicine, cupping, and chuna.</p> Conclusions <p>While KM CPGs have made significant advancements in standardizing care and providing evidence-based recommendations, challenges remain in their implementation, particularly in balancing standardization with KM’s individualized treatment approach. Continuous refinement of guidelines and integration of robust research are necessary to optimize KM's role in evidence-based healthcare. </p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Current Status and Updates of Korean Medicine Clinical Practice Guidelines: A 2024 Review

  • Myung-Ho Kim,
  • Geun-woo Kim,
  • Dong-Il Kim,
  • Min-jeong Kim,
  • Bo-Kyung Kim,
  • Sang-Ho Kim,
  • Eun-jung Kim,
  • Jae-Hong Kim,
  • Jong Uk Kim,
  • Joo-Hee Kim,
  • Jinsung Kim,
  • Dong-Woo Nam,
  • Donghyun Nam,
  • So-jung Park,
  • Jang-Kyung Park,
  • Jae Woo Park,
  • Yong Hyeon Baek,
  • Byung-Kwan Seo,
  • YunKyung Song,
  • Ho-Sueb Song,
  • Byung-Cheul Shin,
  • Seung-ryong Yeom,
  • Jun-Sang Yu,
  • DongHyo Lee,
  • Byung Ryul Lee,
  • Sangkwan Lee,
  • Eun Yong Lee,
  • Eun-Hee Lee,
  • Eui-ju Lee,
  • Junhee Lee,
  • Jin Moo Lee,
  • Hye Lim Lee,
  • Gyu Tae Chang,
  • Insoo Jang,
  • Sun-Yong Chung,
  • Won-Suk Chung,
  • In Chul Jung,
  • Kiho Cho,
  • Jae-Heung Cho,
  • Chung-Sik Cho,
  • Gyooyong Chi,
  • Yoo-min Choi,
  • Jun-Yong Choi,
  • In-Hyuk Ha,
  • Chang-ho Han,
  • Deok-sang Hwang,
  • Eui-Hyoung Hwang,
  • Tae Han Yook

摘要

Background

Korean Medicine (KM) has been a vital part of healthcare, providing holistic treatment approaches for diverse conditions. With the growing demand for integration with conventional medical frameworks, the development of evidence-based clinical practice guidelines (CPGs) has become essential. These guidelines aim to ensure consistent and effective care while enhancing the credibility of KM in the global healthcare community.

Methods

This review comprehensively analyzed the latest KM CPGs to examine their distribution across diseases, levels of evidence, and strengths of recommendations. The analysis categorized guidelines into key clinical focus areas, assessed the supporting evidence, and evaluated the strength of recommendations provided.

Results

KM CPGs primarily address musculoskeletal, symptom-based, mental, and nervous system disorders, reflecting critical areas of clinical application. Most recommendations are supported by moderate evidence, with high-strength (Grade A) recommendations encompassing treatments such as acupuncture, pharmacopuncture, herbal medicine, cupping, and chuna.

Conclusions

While KM CPGs have made significant advancements in standardizing care and providing evidence-based recommendations, challenges remain in their implementation, particularly in balancing standardization with KM’s individualized treatment approach. Continuous refinement of guidelines and integration of robust research are necessary to optimize KM's role in evidence-based healthcare.